Terug
24
Dagbereik
€ 39,24
€ 40,04
52-Weeksbereik
€ 38,13
€ 57,82
Volume
1.580.735
50D / 200D Gem.
€ 48,45
/
€ 47,37
Vorige Slotkoers
€ 39,49
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 19,3 | 0,4 |
| P/B | 2,2 | 2,9 |
| ROE % | 11,6 | 3,9 |
| Net Margin % | 20,3 | 3,8 |
| Rev Growth 5Y % | -1,9 | 10,0 |
| D/E | 0,4 | 0,2 |
Koersdoel Analisten
Hold
€ 54,33
+36.6%
Low: € 50,00
High: € 59,00
Forward K/W
15,69
Forward WPA
€ 2,52
WPA Groei (sch.)
+0,0%
Omzet Sch.
2,22B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 3,54
€ 3,51 – € 3,59
|
2,77B | 2 |
| FY2029 |
€ 3,27
€ 3,25 – € 3,32
|
2,63B | 2 |
| FY2028 |
€ 3,02
€ 2,74 – € 3,66
|
2,49B | 4 |
No quarterly estimates available
Dividend History
Yield
0,01%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Revenue declined -1,85% annually over 5 years
Earnings grew 408,28% over the past year
ROE of 11,57% — decent returns on equity
Net margin of 20,33% shows strong profitability
Debt/Equity of 0,44 — conservative balance sheet
Generating 453,28M in free cash flow
Groei
Revenue Growth (5Y)
-1,85%
Revenue (1Y)5,65%
Earnings (1Y)408,28%
FCF Growth (3Y)23,61%
Kwaliteit
Return on Equity
11,57%
ROIC7,18%
Net Margin20,33%
Op. Margin24,90%
Veiligheid
Debt / Equity
0,44
Current Ratio3,90
Interest Coverage15,65
Waardering
P/E Ratio
19,29
Forward P/EN/A
P/B Ratio2,17
EV/EBITDA17,32
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5,65% | Revenue Growth (3Y) | 3,12% |
| Earnings Growth (1Y) | 408,28% | Earnings Growth (3Y) | 11,57% |
| Revenue Growth (5Y) | -1,85% | Earnings Growth (5Y) | -4,58% |
| Profitability | |||
| Revenue (TTM) | 2,09B | Net Income (TTM) | 424,88M |
| ROE | 11,57% | ROA | 6,75% |
| Gross Margin | 61,79% | Operating Margin | 24,90% |
| Net Margin | 20,33% | Free Cash Flow (TTM) | 453,28M |
| ROIC | 7,18% | FCF Growth (3Y) | 23,61% |
| Safety | |||
| Debt / Equity | 0,44 | Current Ratio | 3,90 |
| Interest Coverage | 15,65 | ||
| Dividends | |||
| Dividend Yield | 0,01% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 19,29 | Forward P/E | N/A |
| P/B Ratio | 2,17 | P/S Ratio | 3,92 |
| PEG Ratio | 0,05 | Forward PEG | N/A |
| EV/EBITDA | 17,32 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 5,53% | ||
| Market Cap | 8,20B | Enterprise Value | 9,01B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,09B | 1,98B | 1,97B | 2,14B | 2,25B |
| Net Income | 424,88M | 83,59M | 341,30M | 423,21M | 512,60M |
| EPS (Diluted) | 2,04 | 0,38 | 1,65 | 2,05 | 2,47 |
| Gross Profit | 1,29B | 967,35M | 1,23B | 1,38B | 1,45B |
| Operating Income | 520,31M | 97,71M | 409,94M | 531,46M | 630,08M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 6,30B | 5,69B | 6,12B | 6,29B | 6,15B |
| Total Liabilities | 2,52B | 2,12B | 2,31B | 2,82B | 3,05B |
| Shareholders' Equity | 3,78B | 3,57B | 3,81B | 3,47B | 3,10B |
| Total Debt | 1,65B | 1,61B | 1,69B | 2,03B | 2,12B |
| Cash & Equivalents | 839,01M | 663,56M | 668,08M | 730,67M | 880,52M |
| Current Assets | 2,00B | 1,96B | 2,15B | 2,39B | 2,11B |
| Current Liabilities | 512,14M | 543,63M | 1,08B | 974,52M | 1,52B |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#930 of 1052
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026